Evaluating a Patient Decision Aid for Buprenorphine in the Emergency Department
This study is looking at a new way to help people with opioid use disorder (OUD) decide about treatment. Researchers are testing a "patient decision aid" (a tool with information) for buprenorphine, a medication used to treat OUD, when it's started in the emergency department. The goal is to see if this tool helps patients understand their options better, feel more comfortable with their decision, and if more people choose to start buprenorphine compared to usual care. You might be able to join if you are 18 or older, have moderate-to-severe OUD, speak and read English, are not currently prescribed medication for OUD, and can access video/email after leaving the emergency department. The study is currently unclear about its recruitment status and plans to enroll 20 participants.
- Study design
- This study is an interventional study, meaning participants will receive a specific intervention. It aims to enroll 20 participants.
- What's involved
- Not specified in the trial record.
- Compensation
- Not stated in the trial record.
- Follow-up
- The primary endpoint, acceptability of the intervention, is measured at Day 1.
AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.
Evaluation of a Patient Decision Aid for Emergency Department Initiated Buprenorphine
At a glance
Conditions
Where it's being run
1 sites across 1 statesStudy leadership
- Lindsey Jennings, MD, MPH · PRINCIPAL_INVESTIGATOR · Medical University of South Carolina
Who to contact
Opens a ready-to-send draft in your own email app — review before sending.
Do you actually qualify for this trial?
Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.
Inclusion
What this trial measures
- Acceptability of Intervention Measure (AIM)Day 1